Dendrimers-Based Drug Delivery System: A Novel Approach in Addressing Parkinson's Disease
Parkinson's disease (PD) is a progressive neurodegenerative disease that is characterized by the loss of dopamine. Since dopamine has trouble entering the blood-brain barrier, the utilization of dendrimers and other nanomaterials is considered for conjugating the neurotransmitter and other PD d...
Saved in:
Main Authors: | Michaella B. Ordonio (Author), Randa Mohammed Zaki (Author), Amal Ali Elkordy (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dendrimers: novel carriers for drug delivery
by: H. S. Chaudhari, et al.
Published: (2016) -
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
by: Kanika Madaan, et al.
Published: (2014) -
Dendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenac
by: Huang B, et al.
Published: (2015) -
Self-Immolative Domino Dendrimers as Anticancer-Drug Delivery Systems: A Review
by: Karolina Kędra, et al.
Published: (2024) -
Anti-biofilm, drug delivery and cytotoxicity properties of dendrimers
by: Christian Kelechi Ezeh, et al.
Published: (2024)